Literature DB >> 20161007

Stable isotope-labeled tracers for the investigation of fatty acid and triglyceride metabolism in humans in vivo.

Faidon Magkos1, Bettina Mittendorfer.   

Abstract

Understanding lipid metabolism and its regulation requires information on the rates at which lipids are produced within the body, absorbed (dietary lipids) into the body, transported within the body, and utilized by various tissues. This article focuses on the use of stable isotope-labeled tracers for the quantitative evaluation of major pathways of fatty acid and triglyceride metabolism in humans in vivo. Adipose tissue lipolysis and free fatty acid appearance in plasma, fatty acid tissue uptake and oxidation, and hepatic very low-density lipoprotein triglyceride secretion are among the metabolic pathways that can be studied by using stable isotope labeled tracers, and will be discussed in detail. The methodology has been in use for many years and is constantly being refined. A variety of tracers and analytical approaches are available and can be used; knowing the advantages, assumptions, and limitations of each is essential for the planning of studies and the interpretation of data, which can provide unique insights into human lipid metabolism.

Entities:  

Year:  2009        PMID: 20161007      PMCID: PMC2758620          DOI: 10.2217/clp.09.9

Source DB:  PubMed          Journal:  Clin Lipidol        ISSN: 1758-4302


  121 in total

1.  Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man.

Authors:  A Aarsland; D Chinkes; R R Wolfe
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

2.  Fractional oxidation of chylomicron-derived oleate is greater than that of palmitate in healthy adults fed frequent small meals.

Authors:  D E Schmidt; J B Allred; C L Kien
Journal:  J Lipid Res       Date:  1999-12       Impact factor: 5.922

Review 3.  Human fat cell lipolysis: biochemistry, regulation and clinical role.

Authors:  Peter Arner
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2005-12       Impact factor: 4.690

4.  Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production.

Authors:  W Wang; A Basinger; R A Neese; B Shane; S A Myong; M Christiansen; M K Hellerstein
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-03       Impact factor: 4.310

5.  Measuring VLDL-triglyceride turnover in humans using ex vivo-prepared VLDL tracer.

Authors:  Lars C Gormsen; Michael D Jensen; Søren Nielsen
Journal:  J Lipid Res       Date:  2005-10-18       Impact factor: 5.922

6.  Stable isotope tracer dilution for quantifying very low-density lipoprotein-triacylglycerol kinetics in man.

Authors:  Labros S Sidossis; Faidon Magkos; Bettina Mittendorfer; Robert R Wolfe
Journal:  Clin Nutr       Date:  2004-08       Impact factor: 7.324

7.  Dietary fat oxidation as a function of body fat.

Authors:  Klaas R Westerterp; Astrid Smeets; Manuela P Lejeune; Mirjam P E Wouters-Adriaens; Margriet S Westerterp-Plantenga
Journal:  Am J Clin Nutr       Date:  2008-01       Impact factor: 7.045

Review 8.  Removal of triacylglycerols from chylomicrons and VLDL by capillary beds: the basis of lipoprotein remnant formation.

Authors:  F Karpe; A S Bickerton; L Hodson; B A Fielding; G D Tan; K N Frayn
Journal:  Biochem Soc Trans       Date:  2007-06       Impact factor: 5.407

9.  Lipolytic response to glucose infusion in human subjects.

Authors:  R R Wolfe; E J Peters
Journal:  Am J Physiol       Date:  1987-02

10.  Plasma free fatty acid transport during prolonged glucose consumption and its relationship to plasma triglyceride fatty acids in man.

Authors:  P J Barter; P J Nestel
Journal:  J Lipid Res       Date:  1972-07       Impact factor: 5.922

View more
  13 in total

1.  Quantification of muscle triglyceride synthesis rate requires an adjustment for total triglyceride content.

Authors:  Rabia Asghar; Maria Chondronikola; Edgar L Dillon; William J Durham; Craig Porter; Zhanpin Wu; Maria Camacho-Hughes; Clark R Andersen; Heidi Spratt; Elena Volpi; Melinda Sheffield-Moore; Labros Sidossis; Robert R Wolfe; Nicola Abate; Demidmaa R Tuvdendorj
Journal:  J Lipid Res       Date:  2018-08-21       Impact factor: 5.922

2.  Estrogen deficiency after menopause does not result in male very-low-density lipoprotein metabolism phenotype.

Authors:  Faidon Magkos; Elisa Fabbrini; B Selma Mohammed; Bruce W Patterson; Samuel Klein; Bettina Mittendorfer
Journal:  J Clin Endocrinol Metab       Date:  2010-05-05       Impact factor: 5.958

Review 3.  Getting the label in: practical research strategies for tracing dietary fat.

Authors:  J E Lambert; E J Parks
Journal:  Int J Obes Suppl       Date:  2012-12-11

4.  Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction.

Authors:  Faidon Magkos; Elisa Fabbrini; B Selma Mohammed; Bruce W Patterson; Samuel Klein
Journal:  Obesity (Silver Spring)       Date:  2010-04-15       Impact factor: 5.002

5.  Reproducibility of glucose, fatty acid and VLDL kinetics and multi-organ insulin sensitivity in obese subjects with non-alcoholic fatty liver disease.

Authors:  F Magkos; E Fabbrini; K Korenblat; A L Okunade; B W Patterson; S Klein
Journal:  Int J Obes (Lond)       Date:  2010-12-21       Impact factor: 5.095

6.  Selective deuterium labeling of the sphingoid backbone: facile syntheses of 3,4,5-trideuterio-d-erythro-sphingosine and 3-deuterio-d-erythro-sphingomyelin.

Authors:  Hoe-Sup Byun; Robert Bittman
Journal:  Chem Phys Lipids       Date:  2010-09-17       Impact factor: 3.329

7.  Methods for quantifying adipose tissue insulin resistance in overweight/obese humans.

Authors:  K W Ter Horst; K A van Galen; P W Gilijamse; A V Hartstra; P F de Groot; F M van der Valk; M T Ackermans; M Nieuwdorp; J A Romijn; M J Serlie
Journal:  Int J Obes (Lond)       Date:  2017-05-03       Impact factor: 5.095

8.  Physiological interindividual variability in endogenous estradiol concentration does not influence adipose tissue and hepatic lipid kinetics in women.

Authors:  Faidon Magkos; Elisa Fabbrini; Bruce W Patterson; Bettina Mittendorfer; Samuel Klein
Journal:  Eur J Endocrinol       Date:  2022-07-21       Impact factor: 6.558

Review 9.  Hepatic Steatosis as a Marker of Metabolic Dysfunction.

Authors:  Elisa Fabbrini; Faidon Magkos
Journal:  Nutrients       Date:  2015-06-19       Impact factor: 5.717

Review 10.  Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease.

Authors:  Sabina Paglialunga; Clayton A Dehn
Journal:  Lipids Health Dis       Date:  2016-09-17       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.